Table 1.

Clinical and US features at 6 months evaluation

EULAR DASUS Features
Synovial hypertrophySynovial Power-DopplerJoints erosionsTenosynovitisAt least one US alteration
no. of pts (%)no. of pts (%)no. of pts (%)no. of pts (%)(%)
Remission, no. of pts (%) (A)17/23 (73.9)11/23 (47.8)5/23 (21.7)11/23 (47.8%)19/23 (82.6)
LDA, no. of pts (%) (B)14/14 (100)11/14 (78.6)5/14 (35.7)6/14 (42.9%)14/14 (100)
MDA, no. of pts (%) (C)22/23 (95.7)19/23 (82.6)7/23 (30.4)11/23 (47.8%)22/23 (95.7)
HDA, no. of pts (%) (D)9/10 (90)9/10 (90)3/7 (30)7/10 (70)10/10 (100)
P valuens0.021nsnsns
P value (A+B vs C+D)ns0.013nsnsns